Traders Watch list: NiSource, Inc (NYSE:NI), Amgen Inc. (NASDAQ:AMGN)


    NiSource, Inc (NYSE:NI)

    NiSource, Inc (NYSE:NI) represented a move of -2.01 percent or $0.3 per share and closed its previous day trading session at $25.36. 4.49 Million Shares were traded in the last trading session with an Average Volume of 3.66 Million Shares. The stock currently has a Market Capitalization of 9.38 Billion.

    NiSource Inc. is one of the largest fully-regulated utility companies in the United States, serving approximately 3.5 million natural gas customers and 500,000 electric customers across seven states through its local Columbia Gas and NIPSCO brands. Based in Merrillville, Indiana, NiSource’s approximately 8,000 employees are focused on safely delivering reliable and affordable energy to their customers and communities they serve.

    The stock traded between $22.44 and $28.11 over 1-Year time period showing its price to sales ratio of 1.86. NiSource, Inc (NYSE:NI) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

    Right now, the stock has a 50-Day Simple Moving Average of $-2.15 and 200-Day Simple Moving Average of $1.68. Its Price to Free Cash Flow is 0 and Price to Book of 1.77.

    Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.

    In the last Quarter, NiSource, Inc (NYSE:NI) reported its Actual EPS of $0.07/share. The analysts offering Earnings Estimates for the company were believing that NiSource, Inc could bring EPS of $0.09/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -22.2 Percent.

    Amgen Inc. (NASDAQ:AMGN)

    In the last trading session, Amgen Inc. (NASDAQ:AMGN) added its value by 1.96% closing at the price of $192.79. The stock currently has market capitalization of 126.21 Billion, with average volume of 2.65 Million shares.

    Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Amgen Inc. (NASDAQ:AMGN) is showing beta of 1.4. This particular value of beta suggests that Amgen Inc. (NASDAQ:AMGN) has historically moved 140% for every 100% move in the benchmark, based on price level.

    EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Amgen Inc. (NASDAQ:AMGN) is at $12.02.

    The stock currently has RSI of 44.01. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

    Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.

    Amgen Inc. (NASDAQ:AMGN) topped its 52-week high price of $210.19 on 09/27/18 and 52-Week Low Price of $163.31 on 04/02/18. The Stock currently has P/E (price to earnings ttm) of 16.04 and Weekly volatility of 3.21% and monthly volatility of 2.73% respectively.